Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists

Bioorganic & Medicinal Chemistry Letters
2014.0

Abstract

Takeda G-protein-coupled receptor 5 (TGR5) is a promising molecular target for metabolic diseases. A series of 4-(2,5-dichlorophenoxy)pyrimidine and cyclopropylmalonamide derivatives were synthesized as potent agonists of TGR5 based on a bioisosteric replacement strategy. Several compounds exhibited improved potency, compared to a reference compound with a pyridine scaffold. The pharmacokinetic profile of the representative compound 18 was considered moderate.

Knowledge Graph

Similar Paper

Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists
Bioorganic & Medicinal Chemistry Letters 2014.0
Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies
Journal of Medicinal Chemistry 2008.0
Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes
Bioorganic & Medicinal Chemistry 2018.0
Design and biological evaluation of tetrahydropyridine derivatives as novel human GPR119 agonists
Bioorganic & Medicinal Chemistry Letters 2020.0
Structure−Activity Relationship Study of Betulinic Acid, A Novel and Selective TGR5 Agonist, and Its Synthetic Derivatives: Potential Impact in Diabetes
Journal of Medicinal Chemistry 2010.0
Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study
Journal of Medicinal Chemistry 2016.0
7-Methylation of Chenodeoxycholic Acid Derivatives Yields a Substantial Increase in TGR5 Receptor Potency
Journal of Medicinal Chemistry 2019.0
Novel 5-nitropyrimidine derivatives bearing endo-azabicyclic alcohols/amines as potent GPR119 agonists
Bioorganic & Medicinal Chemistry 2017.0
Discovery of 2H-Chromen-2-one Derivatives as G Protein-Coupled Receptor-35 Agonists
Journal of Medicinal Chemistry 2017.0
Design, synthesis and biological evaluation of a series of novel GPR40 agonists containing nitrogen heterocyclic rings
Bioorganic & Medicinal Chemistry Letters 2018.0